Literature DB >> 10579235

Characterization of human papillomavirus in airway papillomas by histologic and biochemical analysis.

M Glynn1, T Sanford, L Hoover, W Kinsey, L Dobbs, D Bruegger.   

Abstract

The role of human papillomavirus (HPV) in airway papillomas has been well defined in recent literature. The chronicity and recurrence of papillomas has been postulated to be a result of residual viral genome in tissue treated with standard laser techniques. Thirteen patients with airway papillomas were selected for study with polymerase chain reaction (PCR) methods to detect viral DNA. Specimens taken prior to laser therapy and specimens taken at laser margins were consistently positive for HPV DNA by PCR. The HPV DNA is apparently present in tissues after macroscopic disease has been ablated by laser techniques. Histologic analysis of laser biopsies demonstrated fragments of squamous epithelium with cytologic features of HPV infection. Laser treatment is ineffective in eradicating HPV-infected tissues from airway papillomas, and this finding supports the notion that recurrence is a product of HPV incorporated into tissue not ablated by laser irradiation. Specific methods, results, and clinical correlation will be discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10579235     DOI: 10.1177/000348949910801109

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  2 in total

1.  Expression of matrix metalloproteinases (MMP-2 and MMP-9) in recurrent respiratory papillomas and laryngeal carcinoma: clinical and morphological parallels.

Authors:  Virgilijus Uloza; Vykintas Liutkevičius; Dalia Pangonytė; Viktoras Saferis; Vaiva Lesauskaitė
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-01-23       Impact factor: 2.503

2.  Multicenter initiative seeking critical genes in respiratory papillomatosis.

Authors:  Farrel J Buchinsky; Craig S Derkay; Suzanne M Leal; Joseph Donfack; Garth D Ehrlich; J Christopher Post
Journal:  Laryngoscope       Date:  2004-02       Impact factor: 3.325

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.